Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene (Q45628046)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2004

Language	Label	Description	Also known as
English	Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene	scientific article published in June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-L-iduronidase gene (English)

1 reference

Europe PubMed Central

14 December 2017

vector-borne disease

0 references

author name string

Seth D Hartung

1

1 reference

Europe PubMed Central

14 December 2017

Joel L Frandsen

2

1 reference

Europe PubMed Central

14 December 2017

Dao Pan

3

1 reference

Europe PubMed Central

14 December 2017

Brenda L Koniar

4

1 reference

Europe PubMed Central

14 December 2017

Patrick Graupman

5

1 reference

Europe PubMed Central

14 December 2017

Roland Gunther

6

1 reference

Europe PubMed Central

14 December 2017

Walter C Low

7

1 reference

Europe PubMed Central

14 December 2017

Chester B Whitley

8

1 reference

Europe PubMed Central

14 December 2017

R Scott McIvor

9

1 reference

Europe PubMed Central

14 December 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

14 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

14 December 2017

9

1 reference

Europe PubMed Central

14 December 2017

866-875

1 reference

Europe PubMed Central

14 December 2017

6

1 reference

Europe PubMed Central

14 December 2017

Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Enzyme replacement therapy in feline mucopolysaccharidosis I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Long-term outcome of Hurler syndrome following bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Gene Transfer Strategies for Correction of Lysosomal Storage Disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Gene therapy for mucopolysaccharidosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Murine mucopolysaccharidosis VIL: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

In utero injection of alpha-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Real-time quantitative polymerase chain reaction to assess gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of beta-glucuronidase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Adenovirus-mediated gene therapy for mucopolysaccharidosis VII: involvement of cross-correction in wide-spread distribution of the gene products and long-term effects of CTLA-4Ig coexpression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Light and electron microscopic features of the liver in mucopolysaccharidosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Hurler syndrome: past, present, and future.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Behavioral habituation to spatial novelty: interference and noninterference studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Outcome of second hematopoietic cell transplantation in Hurler syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Retrovirus-mediated transfer of the human alpha-L-iduronidase cDNA into human hematopoietic progenitor cells leads to correction in trans of Hurler fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.03.011

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.03.011

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45628046&oldid=2077442567"